SIM
ARGS

Spark Investment Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

Spark Investment Management’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,718
Closed -$79K – 935
2015
Q4 		$79K Buy
+1,718
New +$145K 0.01% 682

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Spark Investment Management's ARGS Position: Q1 2016 in Review

Spark Investment Management sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2016, closing a stake of 1,718 shares — an estimated $79K sold.

Spark Investment Management first reported a position in ARGS in Q4 2015 and held it in 1 quarter. The position peaked at $79K in Q4 2015. 21 funds tracked by Wall St. Rank hold ARGS as of Q1 2016.

  • Spark Investment Management reported no remaining Argos Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 1,718 Argos Therapeutics, Inc. shares in Q1 2016, an estimated $79K.
  • Spark Investment Management first reported a position in Argos Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Spark Investment Management's Argos Therapeutics, Inc. position peaked at $79K in Q4 2015.
  • 21 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.